No Data
No Data
Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress
Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced that it will present two posters at the
Astria Therapeutics Is Maintained at Outperform by Oppenheimer
Astria Therapeutics Is Maintained at Outperform by Oppenheimer
Express News | Astria Therapeutics : Oppenheimer Cuts Target Price to $25 From $29
Express News | Oppenheimer Maintains Outperform on Astria Therapeutics, Lowers Price Target to $25
Astria Therapeutics Price Target Maintained With a $16.00/Share by HC Wainwright & Co.
Astria Therapeutics Price Target Maintained With a $16.00/Share by HC Wainwright & Co.
Express News | Wedbush Reiterates Outperform on Astria Therapeutics, Maintains $22 Price Target
No Data